Tradestie Institutional Equity Comparison Engine

BHVN vs RARE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BHVN Overall Edge

BHVN Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biohaven Ltd. (BHVN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while RARE counters with relative strength in Valuation. Fundamentally, BHVN trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus RARE at 11.2x Forward P/E and -59.9% operating margin (+8.1% YoY). In options structure, BHVN sits in CONSOLIDATION (18th %ile IV; Dealer Gamma Walls on Pro) against RARE sits in BREAKDOWN (38th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner RARE
BHVN N/M vs RARE 11.2x Fwd P/E
Growth & Margin Winner BHVN
Op Margin 0.0% vs -59.9% ยท YoY +0.0% vs +8.1%
Momentum & Technical Winner BHVN
1Y +72.6% vs -51.5% ยท 52W Pos 59% vs 12%
Options & Structure Winner BHVN
CONSOLIDATION (18th %ile IV) vs BREAKDOWN (38th %ile IV)
BHVN NYSE
Biohaven Ltd.
Pharmaceutical Preparations
$13.95
+0.9% 1D
Market Cap $2.1B
1M Return +29.36%
1Y Return +72.59%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 15.0 Fund 42.0 Flow 68.0 Mom 50.0
RARE NASDAQ
Ultragenyx Pharmaceutical Inc.
Pharmaceutical Preparations
$15.96
-0.78% 1D
Market Cap $1.7B
1M Return +9.73%
1Y Return -51.5%
Forward P/E 11.2x
Unified AI Score
43.8 / 100 HOLD
Tech 36.0 Fund 53.0 Flow 68.0 Mom 56.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BHVN +72.59% RARE -51.5% Spread: +124.09 pp (BHVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BHVN TTM Op. Margin: 0.0% RARE TTM Op. Margin: -59.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BHVN vs RARE. Trailing 12-month operating profitability (BHVN 0.0% vs RARE -59.9%) and valuation multiples (BHVN N/M vs RARE 11.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BHVN (4) vs RARE (5)
Institutional Metric BHVN RARE Criterion Row Winner
Market Capitalization Scale $2.1B $1.7B Larger Scale BHVN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M 11.2x Lower Multiple RARE
Revenue Growth (YoY) Growth +0.0% +8.1% Higher Growth RARE
Operating Margin (TTM) Profitability 0.0% -59.9% Higher Margin BHVN
Net Profit Margin Profitability 0.0% -71.8% Higher Margin BHVN
Return on Equity (ROE) Capital Efficiency -799.5% -608.5% Higher ROE RARE
52-Week Range Position Momentum 59% ($8โ€“$18) 12% ($13โ€“$40) Stronger Trend BHVN
Beta / 30D Volatility Risk Regime 1.40ฮฒ ยท 111% Vol 1.40ฮฒ ยท 57% Vol Lower Realized Risk RARE
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 43.8 / 100 (HOLD) Higher Composite RARE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BHVN vs RARE Buy Guide
BHVN CONSOLIDATION
91d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live BHVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RARE BREAKDOWN
93d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live RARE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BHVN nor RARE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.